Tags

Type your tag names separated by a space and hit enter

Childhood community-acquired pneumonia.
Semin Respir Infect. 1999 Jun; 14(2):163-72.SR

Abstract

Much of what we know about childhood community-acquired pneumonia in developed countries comes from studies in Europe, where approximately 2.5 million cases of childhood pneumonia occur yearly. Streptococcus pneumoniae, Mycoplasma pneumoniae, and respiratory syncytial virus are the most common causative agents. Blood culture is seldom positive and mortality is very low in developed countries. Tachypnea and crackles on auscultation are the major findings suggesting pneumonia, but their sensitivity and specificity are not high enough, and, if possible, a radiograph of the chest should be obtained to confirm the diagnosis. Recommendations for antibiotic treatment vary. Based on the etiologic studies we suggest macrolides as the first choice in outpatients and depending on the clinical picture and severity of the illness penicillin G, macrolide, or cefuroxime plus macrolide in hospitalized patients. The recovery of children with pneumonia is usually rapid and in uncomplicated cases routine follow-up radiographs and check-ups are unnecessary.

Authors+Show Affiliations

Department of Pediatrics, Turku University Hospital, Finland.No affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

10391410

Citation

Ruuskanen, O, and J Mertsola. "Childhood Community-acquired Pneumonia." Seminars in Respiratory Infections, vol. 14, no. 2, 1999, pp. 163-72.
Ruuskanen O, Mertsola J. Childhood community-acquired pneumonia. Semin Respir Infect. 1999;14(2):163-72.
Ruuskanen, O., & Mertsola, J. (1999). Childhood community-acquired pneumonia. Seminars in Respiratory Infections, 14(2), 163-72.
Ruuskanen O, Mertsola J. Childhood Community-acquired Pneumonia. Semin Respir Infect. 1999;14(2):163-72. PubMed PMID: 10391410.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Childhood community-acquired pneumonia. AU - Ruuskanen,O, AU - Mertsola,J, PY - 1999/7/3/pubmed PY - 1999/7/3/medline PY - 1999/7/3/entrez SP - 163 EP - 72 JF - Seminars in respiratory infections JO - Semin Respir Infect VL - 14 IS - 2 N2 - Much of what we know about childhood community-acquired pneumonia in developed countries comes from studies in Europe, where approximately 2.5 million cases of childhood pneumonia occur yearly. Streptococcus pneumoniae, Mycoplasma pneumoniae, and respiratory syncytial virus are the most common causative agents. Blood culture is seldom positive and mortality is very low in developed countries. Tachypnea and crackles on auscultation are the major findings suggesting pneumonia, but their sensitivity and specificity are not high enough, and, if possible, a radiograph of the chest should be obtained to confirm the diagnosis. Recommendations for antibiotic treatment vary. Based on the etiologic studies we suggest macrolides as the first choice in outpatients and depending on the clinical picture and severity of the illness penicillin G, macrolide, or cefuroxime plus macrolide in hospitalized patients. The recovery of children with pneumonia is usually rapid and in uncomplicated cases routine follow-up radiographs and check-ups are unnecessary. SN - 0882-0546 UR - https://www.unboundmedicine.com/medline/citation/10391410/Childhood_community_acquired_pneumonia_ DB - PRIME DP - Unbound Medicine ER -